EUROAPI Hungary Ltd.
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Medicinal Chemicals and Botanical Products, Lessors of Real Property, Not Elsewhere Classified, Land Subdividers and Developers, Except Cemeteries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about EUROAPI Hungary Ltd.
Live alerts from global media, monitored by Business Radar
2022-05-06 (pharmaphorum.com)
Sanofi ingredients spin-out EuroAPI rises on market debut
Sanofi has completed the spin-out of its pharma ingredients business EuroAPI, with shares in the new company rising more than 3% on its starting price of €12 in early trading on the Euronext exchange this morning in a declining market.
Read more
2022-05-06 (reuters.com)
EuroAPI gains on market debut after spin-off from Sanofi
Shares in EuroAPI , the drug ingredients business spun off from Sanofi , rose on their Paris stock market debut on Friday, defying a wider market decline.
Read more